share_log

HOYA Group Company, PENTAX of America, Inc. and MAGENTIQ EYE Ltd. Announce Their Intention to Form a Distribution Partnership for the U.S Market

HOYA Group Company, PENTAX of America, Inc. and MAGENTIQ EYE Ltd. Announce Their Intention to Form a Distribution Partnership for the U.S Market

豪雅集團公司、美國賓得公司和MAGENTIQ EYE Ltd.宣佈打算在美國市場建立分銷合作伙伴關係
PR Newswire ·  05/17 22:00

WASHINGTON D.C., May 17, 2024 /PRNewswire/ -- HOYA Group Company, PENTAX of America, Inc. (PENTAX Medical) and MAGENTIQ-EYE Ltd., an AI medical device company, announced today their intention to form a partnership in the field of AI in Gastroenterology and to examine further collaboration and strategic partnerships.

華盛頓特區,2024年5月17日 /PRNewswire/ — HOYA集團公司、美國賓得公司(PENTAX Medical)和人工智能醫療器械公司MAGENTIQ-EYE Ltd.今天宣佈,他們打算在胃腸病學人工智能領域建立合作伙伴關係,並研究進一步的合作和戰略合作伙伴關係。

Pending field trials and customer demonstrations to be conducted over the next several months, the companies expect to formalize an agreement as a first step in this partnership, by which PENTAX Medical will distribute the MAGENTIQ-COLO AI-assisted lesion detection device in the U.S.A. beginning October 1st, 2024. The system will be demonstrated at the upcoming Digestive Disease Week (DDW) in Washington D.C., U.S.A.

在未來幾個月進行現場試驗和客戶演示之前,兩家公司預計將正式達成協議,作爲這種合作的第一步,賓得醫療將根據該協議,從2024年10月1日起在美國分銷MAGENTIQ-COLO人工智能輔助病變檢測設備。該系統將在即將在美國華盛頓特區舉行的消化疾病周(DDW)上進行演示。

MAGENTIQ-COLO is a cutting-edge system for the detection of gastrointestinal lesions in colonoscopies. Successfully validated in an international multicenter, randomized, controlled trial (RCT) with 950 enrolled patients at 10 hospitals in Europe, United States and Israel, its outstanding diagnostic capabilities are setting new standards in endoscopic AI.

MAGENTIQ-COLO是一款用於在結腸鏡檢查中檢測胃腸道病變的尖端系統。其卓越的診斷能力在一項針對歐洲、美國和以色列10家醫院的950名入組患者的國際多中心、隨機、對照試驗(RCT)中成功驗證,其卓越的診斷能力正在爲內窺鏡人工智能樹立新標準。

"We are excited to bring the MAGENTIQ-COLO device to the GI community in the U.S. Together with PENTAX Medical's product portfolio, we are confident to provide a smart solution in colonoscopy and contribute further to colorectal cancer prevention", says David Harrison, President PENTAX of America, Inc.

美國賓得公司總裁戴維·哈里森說:“我們很高興能將MAGENTIQ-COLO設備帶到美國胃腸道界,再加上賓得醫療的產品組合,我們有信心提供結腸鏡檢查的智能解決方案,進一步爲結直腸癌的預防做出貢獻。”

"Partnering with PENTAX Medical is an important milestone for us, as it opens new opportunities to introduce our game changing product to the U.S. market, benefiting doctors and their patients and saving more lives", says Dror Zur, Founder & CEO of MAGENTIQ-EYE.

MAGENTIQ-EYE創始人兼首席執行官德羅爾·祖爾說:“與賓得醫療合作對我們來說是一個重要的里程碑,因爲它爲將我們的顛覆性產品推向美國市場開闢了新的機會,使醫生及其患者受益,挽救了更多生命。”

About MAGENTIQ-EYE Ltd.
Founded in 2014, MAGENTIQ-EYE offers a groundbreaking AI-aided colonoscopy solution that offers one of the best performances known today. With worldwide recognition from the gastroenterology community, and dozens of procedures performed every day with the assistance of MAGENTIQ-COLO, we are setting the new standard of colonoscopy, and saving more and more lives.

關於 MAGENTIQ-EYE 有限公司
MAGENTIQ-EYE 成立於 2014 年,提供突破性的人工智能輔助結腸鏡檢查解決方案,提供當今已知的最佳性能之一。隨着胃腸病學界的全球認可,以及在MAGENTIQ-COLO的協助下每天進行的數十例手術,我們正在設定結腸鏡檢查的新標準,挽救越來越多的生命。

About PENTAX Medical

關於賓得醫療

PENTAX Medical is a division of HOYA Group. The company's mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. PENTAX Medical strives to align with the healthcare community's Triple Aim goals through transparent partnerships with its customers and by providing the highest quality solutions to help them reach their goals, including enabling customers to improve patient outcomes by offering evidence-based solutions across the continuum of care; ensuring value by supporting the customers to improve their efficiency and minimize their healthcare costs; and enriching patient and provider's experience by empowering every member of the care team to achieve optimal outcomes through products, education, and support. Focused on the outcome instead of technological features, PENTAX Medical listens to the healthcare community and their patients, understands their daily obstacles and helps improve endoscopy with smart innovations.

賓得醫療是豪雅集團的一個分支機構。該公司的使命是通過提供最好的內窺鏡產品和服務,以質量、臨床相關創新和簡單性爲重點,提高患者護理標準和醫療保健服務質量。PENTAX Medical致力於通過與客戶建立透明的合作伙伴關係,並通過提供最優質的解決方案來幫助他們實現目標,包括通過在整個護理過程中提供循證解決方案來幫助客戶改善患者的預後;通過支持客戶提高效率和最大限度地降低醫療成本來確保價值;通過授權護理團隊的每位成員實現最佳療效來豐富患者和提供者的體驗通過產品、教育和支持。PENTAX Medical專注於結果,而不是技術特徵,傾聽醫療界及其患者的意見,了解他們的日常障礙,並通過智能創新幫助改善內窺鏡檢查。

For more information:

欲了解更多信息:

About HOYA

關於 HOYA

Founded in 1941 in Tokyo, Japan, HOYA Corporation is a global technology and med-tech company and a leading supplier of innovative high-tech and medical products. HOYA is active in the fields of lifecare and information technology, providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses, as well as key components for semiconductor devices, LCD panels, and hard disk drives. With over 150 offices and subsidiaries worldwide, HOYA currently employs a multinational workforce of 36,000 people. For more information, please visit:

HOYA Corporation 於 1941 年在日本東京成立,是一家全球技術和醫療技術公司,也是創新高科技和醫療產品的領先供應商。HOYA活躍於生命護理和信息技術領域,提供眼鏡、醫用內窺鏡、人工晶體、光學鏡片以及半導體設備、液晶面板和硬盤驅動器的關鍵組件。HOYA 在全球擁有 150 多個辦事處和子公司,目前擁有一支由 36,000 名員工組成的跨國員工。欲了解更多信息,請訪問:

SOURCE HOYA Corporation PENTAX Medical

來源 HOYA 公司 PENTAX Medical

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論